medigraphic.com
ISSN 0016-3813 (Print)

2018, Number 5

<< Back Next >>

Gac Med Mex 2018; 154 (5)

Retrasplante cardiaco electivo. Primer caso en México

Careaga-Reyna G, Zetina-Tun HJ

Language: Spanish
References: 19
Page: 617-619
PDF size: 122.59 Kb.


ABSTRACT

Orthotopic cardiac retransplantation is used to treat transplanted cardiac graft end-stage failure. We present the first case of successful elective cardiac retransplantation in Mexico. It was a 25-year old male with heart transplantation who developed graft-resistant chronic vasculopathy. He underwent elective retransplantation in September 2017; complications during postoperative evolution were treated with favorable response. He was discharged owing to improvement at four weeks postoperatively. It is concluded that in adequately selected cases and comprehensively assessed, cardiac retransplantation is an appropriate option to treat cardiac graft failure.


REFERENCES

  1. Careaga-Reyna G, Zetina-Tun H, Lezama-Urtecho CA. Programa de trasplante cardiaco de la Unidad Médica de Alta Especialidad, Hospital General Dr. Gaudencio González Garza del Centro Médico Nacional La Raza. Rev Invest Clin. 2011;63(Supl 1):85-90.

  2. Topkara VK, Dang NC, Cheema JR, Barbato R, Cavallo M, Liu JF, et al. A decade experience of cardiac retransplantation in adult recipients. J Heart Lung Transplant. 2005;24(11):1745-1750. DOI: 10.1016/j. healun.2005.02.015

  3. Mehra MR, Crespo-Leiro MG, Dipchand A, Ensminger SM, Hiemann NE, Kobashigawa JA, et al. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant. 2010;29(7):717-727. DOI: 10.1016/j.healun.2010.05.017

  4. Magee JC, Barr ML, Basadonna GP, Johnson MR, Mahadevan S, Mc- Bride MA, et al. Repeat organ transplantation in the United States, 1996-2005. Am J Transplant. 2007;7(5 Pt 2):1424-1433. DOI: 10.1111/j.1600-6143.2007.01786 x

  5. Radovancevic B, McGiffin DC, Kobashigawa JA, Cintron GB, Mullen GM, Pitts DE, et al. Retransplantation in 7,290 primary transplant patients: a 10-year multiinstitutional study. J Heart Lung Transplant. 2003;22:862- 868. DOI: 10.1016/S1053-2498(02)00803-3

  6. Pozzi C, d’Alessandro C, Fernandez F, Nguyen A, Pavie A, Leprince P, et al. Who gets a second heart? A current picture of cardiac retransplantation. Transplant Proc 2014; 46; 202-207. DOI: 10.1016/j.transproceed.2013.08.109

  7. Srivastava R, Keck BM, Bennett LE, Hosenpud JD. The results of cardiac retransplantation: an analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. Transplantation. 2000;70(4):606-612.

  8. Johnson MR, Aaronson KD, Canter CE, Kirklin JK, Mancini DM, Mehra MR, et al. Heart retransplantation. Am J Transplant. 2007;7(9):2075‑2081. DOI: 10.1111/j.1600-6143 2007.01902.x

  9. Saito A, Novick RJ, Kiaii B, McKenzie FN, Quantz M, Pflugfelder P, et al. Early and late outcomes after cardiac retransplantation. Can J Surg. 2013;56(1):21-26. DOI: 10.1503/cjs.012511

  10. Doshi AA, Rogers J, Kern MJ, Hauptman PJ. Effectiveness of percutaneous coronary intervention in cardiac allograft vasculopathy. Am J Cardiol. 2004;93(1):90-92. DOI: 10.1016/j.amjcard 2003.08.075

  11. Taylor DO, Edwards LB, Mohacsi PJ, Boucek MM, Trulock EP, Keck BM, et al. The Registry of the International Society for Heart and Lung Transplantation: twentieth official adult heart transplant report-2003. J Heart Lung Transplant. 2003;22(6):616–624.

  12. Patel VS, Radovancevic B, Springer W, Frazier OH, Massin E, Benrey J, et al. Revascularization procedures in patients with transplant coronary artery disease. Eur J Cardiothorac Surg. 1997;11(5): 895-901.

  13. Tham EB, Yeung AC, Cheng CW, Bernstein D, Chin C, Feinstein JA. Experience of percutaneous coronary intervention in the management of pediatric cardiac allograft vasculopathy. J Heart Lung Transplant. 2005;24(6):769-773. DOI: 10.1016/j.healun.2004.04.009

  14. Copeland JG, Griepp RB, Bieber CP, Billingham M, Schroeder JS, Hunt S, et al. Successful retransplantation of the human heart. J Thorac Cardiovasc Surg. 1977;73(2):242-247.

  15. Tjang YS, Tenderich G, Hornik L, Körfer R. Cardiac retransplantation in adults: an evidence-based systematic review. Thorac Cardiovasc Surg. 2008;56(6):323-327. DOI: 10.1055/s-2008-1038662

  16. Tsao L, Uriel N, Leitz K, Naka Y, Mancini D. Higher rate of comorbidities after cardiac retransplantation contributes to decreased survival. J Heart Lung Transplant. 2009;28(10):1072-1074. DOI: 10.1016/j.healun.2009.06.004

  17. Grun S, Ceruti B, Chiesa P, Díaz P, Manfredi A, Leone R. Retrasplante cardíaco: a propósito del primer caso en Uruguay. Rev Urug Cardiol. 2006;21(2):124-130. Disponible en: http://www.scielo.edu.uy/scielo. php?script=sci_arttext&pid=S1688-04202006000200004

  18. Goldraich LA, Stehlik J, Kucheryavayya AY, Edwards LB, Ross HJ. Retransplant and medical therapy for cardiac allograft vasculopathy: International Society for Heart and Lung Transplantation Registry Analysis. Am J Transplant. 2016;16:301-309. DOI: 10.1111/ ajt.13418

  19. Careaga-Reyna G, Zetina-Tun HJ, Lezama-Urtecho CA, Arellano- Juárez L, Alvarez-Sánchez LM. Trasplante de corazón en pacientes con cirugía cardiaca previa. Cir Cardiov. 2017;24(1):22-25. DOI: 10.1016/j. circv.2016.09.010




2020     |     www.medigraphic.com